Related references
Note: Only part of the references are listed.Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis
Christoph Grani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)
Yehuda Adler et al.
EUROPEAN HEART JOURNAL (2015)
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
Raymond H. Chan et al.
CIRCULATION (2014)
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
Perry M. Elliott et al.
EUROPEAN HEART JOURNAL (2014)
Prevalence of cardiomyopathy in asymptomatic patients with left bundle branch block referred for cardiovascular magnetic resonance imaging
Masliza Mahmod et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2012)
Assessment of Left Ventricular Hypertrophy in a Trained Athlete: Differential Diagnosis of Physiologic Athlete's Heart From Pathologic Hypertrophy
Antonio Pelliccia et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2012)
Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy
John J. Green et al.
JACC-CARDIOVASCULAR IMAGING (2012)
Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol
Choon Ta Ng et al.
EUROPACE (2011)
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Controversial Issues in the Management of Pericardial Diseases
Massimo Imazio et al.
CIRCULATION (2010)
Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Barry J. Maron
CIRCULATION (2010)
Recommendations for interpretation of 12-lead electrocardiogram in the athlete
Domenico Corrado et al.
EUROPEAN HEART JOURNAL (2010)
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Rory O'Hanlon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy
Juan R. Gimeno et al.
EUROPEAN HEART JOURNAL (2009)
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Perry Elliott et al.
EUROPEAN HEART JOURNAL (2008)
Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis
Antonio Pelliccia et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2006)
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy
Kevin M. Harris et al.
CIRCULATION (2006)
Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy
P. M. Elliott et al.
HEART (2006)
Contemporary definitions and classification of the cardiomyopathies - An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; And Council on Epidemiology and Prevention
BJ Maron et al.
CIRCULATION (2006)
Colchicine in addition to conventional therapy for acute pericarditis - Results of the colchicine for acute pericarditis (COPE) trial
M Imazio et al.
CIRCULATION (2005)
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
AS Adabag et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia
A Tabib et al.
CIRCULATION (2003)
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients
L Monserrat et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy - A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
BJ Maron et al.
EUROPEAN HEART JOURNAL (2003)
Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy
I Olivotto et al.
CIRCULATION (2001)
Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with 'classical' clinical diagnosis of idiopathic dilated cardiomyopathy
M Cicoira et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
PM Elliott et al.
LANCET (2001)
Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
PM Elliott et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.
P Spirito et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.
RE McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
BJ Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
